Related Experiment Video
Updated: May 22, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
New immediate release formulation for deterring abuse of methadone
A O Betancourt1, P M Gosselin, R K Vinson
1Pharmaceutical Research and Development, Corealis Pharma Inc., Laval, Qc, Canada.
Context:
Drug abusers are known to take a dosage form containing an opioid analgesic and crush, shear, grind, chew, or dissolve it in water or in alcohol, in order to extract the opioid component.
Objective:
Develop an anti abuse immediate release formulation using methadone as model drug.
Materials And Methods:
Tablets combining methadone and alkalizing agents were manufactured. A methadone assay was used to determine extraction efficiency from tablets in aqueous and alcohol solvents. In vitro dissolution testing was used to determine drug release in different media.
Results And Discussions:
Meglumine-based formulations prevented extraction of 70 to 100% of methadone from tablets. Addition of this alkalizing agent caused methadone to precipitate out of a solution along with other ingredients and be retained on standard filters. Meglumine-containing and control tablets showed similar dissolution profiles in acidic media, suggesting adequate solubilisation of the drug early in the gastrointestinal tract. Finally, stability upon storage of the formulations for 6 months at 25°C/60%RH and 40°C/75%RH was confirmed.
Conclusion:
Incorporation of an alkalizing agent into methadone tablets significantly reduced the preparation of a methadone solution for intravenous administration and abuse, while allowing the formulation to release methadone in gastric media and provide desired pharmacological effect.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Oral Drug Delivery Systems: Continuous-Release Systems
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Modified-Release Drug Delivery Systems: Overview
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug Delivery Systems: Different Types

